ASP3026
ASP3026 is a small molecule inhibitor under investigation for the treatment of advanced solid tumors and lymphomas, particularly those driven by ALK or ROS1 alterations. It is utilized in preclinical research to study oncogenic signaling pathways and has demonstrated activity in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
1097917-15-1
Product Name Alternative
Inhibit, Inhibitor, Cluster of differentiation 246, CD246, ALK, ALK tyrosine kinase receptor, ASP 3026, ASP3026, ASP-3026, Apoptosis, Anaplastic lymphoma kinase (ALK), Anaplastic lymphoma kinase
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Molecular Biology, Protein Biochemistry, Signal Transduction, Stem Cell & Developmental Biology
Purity
≥95% (May vary between batches)
Solubility
DMSO:11.6 mg/mL (19.97 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.44 mM)
Smiles
COc1cc (ccc1Nc1ncnc (Nc2ccccc2S (=O) (=O) C (C) C) n1) N1CCC (CC1) N1CCN (C) CC1
Molecular Formula
C29H40N8O3S
Molecular Weight
580.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1083696 1 Each
2,6-Dimethyl-4-cyanophenylboronic acid pinacol ester
Sign In for Pricing
View Details 